Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Lexicon Pharmaceuticals (LXRX) Accumulated Depreciation & Amortization (2023 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Accumulated Depreciation & Amortization for 6 consecutive years, with $621000.0 as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 16.29% to $621000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $621000.0 through Dec 2025, up 16.29% year-over-year, with the annual reading at $621000.0 for FY2025, 16.29% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $621000.0 at Lexicon Pharmaceuticals, up from $534000.0 in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $621000.0 in Q4 2025, with the low at $112000.0 in Q1 2023.
  • Average Accumulated Depreciation & Amortization over 3 years is $368888.9, with a median of $407000.0 recorded in 2023.
  • Peak annual rise in Accumulated Depreciation & Amortization hit 28.57% in 2024, while the deepest fall reached 3.61% in 2024.
  • Over 3 years, Accumulated Depreciation & Amortization stood at $554000.0 in 2023, then dropped by 3.61% to $534000.0 in 2024, then increased by 16.29% to $621000.0 in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $621000.0, $534000.0, and $409000.0 for Q4 2025, Q4 2024, and Q3 2024 respectively.